Expression of breast cancer resistance protein (BCRP) in esophageal cancers (EC)

被引：0
|
作者：
Bharthuar, A. [1 ,2 ]
Khoury, T. [1 ,2 ]
Haas, K. N. [1 ,2 ]
Mashtare, T. [1 ,2 ]
Black, J. [1 ,2 ]
Baer, M. [1 ,2 ]
Yang, G. [1 ,2 ]
Khushalani, N. [1 ,2 ]
Iyer, R. V. [1 ,2 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] Univ Maryland, Baltimore, MD 21201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13529
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia
    van der Kolk, DM
    Vellenga, E
    Scheffer, GL
    Müller, M
    Bates, SE
    Scheper, RJ
    de Vries, EGE
    BLOOD, 2002, 99 (10) : 3763 - 3770
  • [22] Placental expression of breast cancer resistance protein (BCRP1) in the mouse: Fetal protection.
    Kalabis, GM
    Morassaei, S
    Petropoulos, S
    Gibb, W
    Mattliews, SG
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) : 320A - 320A
  • [23] INTERACTIONS OF ORAL MOLECULAR EXCIPIENTS WITH BREAST CANCER RESISTANCE PROTEIN (BCRP).
    Zou, L.
    Pottel, J.
    Khuri, N.
    Ngo, H.
    Ni, Z.
    Tsakalozou, E.
    Warren, M.
    Huang, Y.
    Shoichet, B.
    Giacomini, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S84 - S84
  • [24] Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators
    Zattoni, Ingrid Fatima
    Delabio, Leticia Carani
    Dutra, Julia de Paula
    Kita, Diogo Henrique
    Scheiffer, Gustavo
    Hembecker, Marina
    Pereira, Giovana da Silva
    Moure, Vivian Rotuno
    Valdameri, Glaucio
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 237
  • [25] Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
    MM van den Heuvel-Eibrink
    EAC Wiemer
    A Prins
    JPP Meijerink
    PJM Vossebeld
    B van der Holt
    R Pieters
    P Sonneveld
    Leukemia, 2002, 16 : 833 - 839
  • [26] Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
    van den Heuvel-Eibrink, MM
    Wiemer, EAC
    Prins, A
    Meijerink, JPP
    Vossebeld, PJM
    van der Holt, B
    Pieters, R
    Sonneveld, P
    LEUKEMIA, 2002, 16 (05) : 833 - 839
  • [27] Interactions of Oral Molecular Excipients with Breast Cancer Resistance Protein, BCRP
    Zou, Ling
    Pottel, Joshua
    Khuri, Natalia
    Ngo, Huy X.
    Ni, Zhanglin
    Tsakalozou, Eleftheria
    Warren, Mark S.
    Huang, Yong
    Shoichet, Brian K.
    Giacomini, Kathleen M.
    MOLECULAR PHARMACEUTICS, 2020, 17 (03) : 748 - 756
  • [28] Novel lead for potent inhibitors of breast cancer resistance protein (BCRP)
    Pick, Anne
    Mueller, Henrik
    Wiese, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 180 - 183
  • [29] Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
    L Austin Doyle
    Douglas D Ross
    Oncogene, 2003, 22 : 7340 - 7358
  • [30] Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
    Doyle, LA
    Ross, DD
    ONCOGENE, 2003, 22 (47) : 7340 - 7358
12345